Sensors

The opportunity to collect movement data from smartphones for prolonged periods has opened new perspectives in the field of clinical movement analysis. However, when monitoring peoples mobility in free-living conditions, smartphone placement can influence the validity of the extracted digital mobility outcome. This study aimed to develop and validate an automatic smartphone placement recognition classifier and to investigate potential critical factors that can influence performance. The classifier was trained on data from 15 healthy participants using inertial signals collected from smartphones placed at six body placements during free-living walking and externally validated on over 3,000 individuals from external datasets, including blind participants and patients with cardiovascular or Parkinsons disease. A decision-tree ensemble model was developed using feature subsets of increasing dimensionality, with the optimal subset comprising 50 features. Classification accuracy increased consistently when front and back pocket placements were aggregated (81.1%) and further improved when coat pocket was also included in the pocket class (88.5%), underscoring the challenge of distinguishing between fine-grained pocket placements. The best-recognized placements across the external datasets were lower back (precision: 100%, recall: 72.5%), hand (precision: 94.2%, recall: 94.5%), and the aggregated pocket class (precision: 86.7%, recall: 90.2%). Recognition accuracy changed across cohorts (0.73 - 0.85), activities (0.63 - 0.94) and speed (0.79 - 0.87), however it stayed consistent across various technological and environmental factors. Overall, this study demonstrates the feasibility of robust placement recognition in walking and underscores the importance of accounting for key influencing factors when designing frameworks intended for deployment in heterogeneous real-world or clinical contexts. HighlightsO_LIMachine learning accurately identifies smartphone placement during real-world gait C_LIO_LISix on-body placements recognized, including pockets, hand, bag, and lower-back C_LIO_LIFree-living data used for training, ensuring robust performance across conditions C_LIO_LIFeature selection and hyperparameter tuning optimize classification accuracy C_LIO_LIExternal validation confirms generalizability across >3,000 healthy and diseased adults C_LI

With the emergence of electroencephalography (EEG) as a tool in the cognitive domain, new demands are being placed on the technology to keep up with functional applications, especially in the context of at-home neural monitoring. New use cases have fostered development of wearable EEG (wEEG) devices: portable, low-cost headsets used for EEG monitoring. This evolution of technology and application has not been accompanied by development in technology evaluation, often relying on function-agnostic markers to assess devices for efficacy in this new space. With current methods limited in scope, this study designed, tested and evaluated a novel functionally-focused comparative protocol for wEEG devices. Eight participants undertook a protocol for the evaluation of four established wEEG devices, assessing cognitive resolution and general usability. Compared to a well-established traditional analysis method (eyes open/eyes closed protocol), the novel design proposed here enabled the same analysis of headset resolution, while also providing additional context into user preferences and opening downstream possibilities for specific cognitive insights. Future research could enable the development of this protocol into a standardised method to ensure the performance of wEEG technology can satisfy emerging clinical needs.

Background and Objectives Patients with peripheral neuropathies (PN) commonly exhibit balance impairment. In clinical practice, balance is typically assessed using the Rombergs test and ataxia scales, which rely on examiner interpretation, while objective biomarkers for quantifying balance remain lacking. Wearable sensors are valuable tools for objectively quantifying gait abnormalities in PN patients and may capture clinically meaningful changes over time. By integrating these parameters, artificial intelligence (AI) can assist in generating a digital score that enables easy, objective, and reproducible monitoring of patients postural balance. This study aims to generate and assess an AI-generated digital Rombergs test to quantify balance impairments in a cohort of PN patients. Methods PN patients were assessed in a longitudinal study using a wearable system composed of inertial sensors placed on the trunk and plantar pressure sensors integrated in insoles. Patients performed the Rombergs test under both eyes-open and eyes-closed conditions and were classified according to ataxia severity (mild, moderate, or severe) following the score obtained in item 1 of MICARS and SARA scales. Results We included 97 patients with PN (including autoimmune and hereditary polyneuropathies), and 117 healthy controls (HC). Significant differences in trunk sway and center of pressure (COP) were observed between groups, particularly with eyes closed. Using wearable sensor parameters, we developed an AI digital Rombergs test, which correlated with clinician-rated Rombergs test performance and distinguished patients with and without ataxia (AUC=0.632) and across different PN pathologies. Longitudinally, digital Rombergs test and iRODS showed concordant trajectories. Also, changes [≥]25% in the score were associated with clinical changes in ataxia severity measured by an increase in MICARS-SARA score (+1.42 points), whereas improvement was associated with a decrease (-0.20 points) in the scale. Discussion This study demonstrates that wearable sensors are useful to detect and quantify balance impairment. The AI-generated Rombergs test is an objective and reproducible tool for postural balance assessment, with robust discriminatory performance across clinical ataxia severity in PN. Scores longitudinal changes aligned with clinical severity, supporting its potential for monitoring disease progression and treatment response. Its strong association with balance measures reinforces its role as a quantitative biomarker of postural control in ataxia patients.

Non-invasive wrist pulse monitoring has been integrated into various medical systems for cardiovascular assessment. However, different definitions of pulse transit time are used in the literature, and their statistical behavior when measured locally at the wrist using pressure sensors has not been systematically examined. Wearable wristbands designed to measure pulse transit time (PTT) have emerged as valuable tools for evaluating cardiac activity. While several algorithms have been developed to predict blood pressure using PTT, it is well recognized that PTT and its inverse parameter, pulse wave velocity (PWV), exhibit temporal variability. In this study, PTT was explicitly measured at the wrist's radial artery to investigate its statistical variation and relationship with different arterial pressures. The experiment exhibits two distinct methodologies for PTT computation using onset-based and peak based measurements. Data were recorded across five cuff pressure levels at 20, 40, 60, 80, and 100 mmHg using the pulse pressure sensor (PPS). PTTonset time shows lower coefficient of variation as compared to PTTpeak time within the 100 mmHg pressure range. The weak correlation coefficient is recorded between PTT values. However, dynamic time warping (DTW) analysis revealed a notable similarity in the time series of PTTonset and PTTpeak, regardless of the applied pressure level. For the multi participant dataset, the mean DTW distances ranged from 0.029 to 0.046 across the tested cuff pressures, illustrating consistent similarity between PTTonset and PTTpeak over time. The objective of this study is to examine the statistical behavior, stability, and temporal similarity of the two commonly used PTT definitions when measured at the radial artery using pressure sensors. Statistical analysis shows consistent differences between the two PTT definitions across participants. PTTonset shows lower variation than PTTpeak. However, PTTpeak requires simpler computation and produces fewer detection errors, while PTTonset provides lower statistical variation.

BACKGROUND: Aging and Parkinsons disease (PD) reduce gait automaticity and increase cognitive demand during walking. Although dual task (DT) paradigms investigate cognitive motor interference, evidence remains limited by heterogeneous tasks, predominant focus on prefrontal cortex (PFC) activity, and variability in functional near infrared spectroscopy (fNIRS) methods. This study investigates whether longitudinal changes in cortical activation during DT walking differ among young adults, older adults, and individuals with PD, and how these changes relate to DT costs over 5 years. METHODS: This longitudinal observational study follows STROBE and fNIRS guidelines and will be conducted in a controlled laboratory (Rede Amparo, CEPID NeuroMat, University of Sao Paulo). Participants will be evaluated annually under three randomized conditions: motor single-task walking, cognitive single task phonemic verbal fluency and DT walking with phonemic verbal fluency, each repeated 10 times. The primary outcome measure will be longitudinal changes in cortical activation during DT walking, quantified by oxygenated hemoglobin (HbO) signals measured with fNIRS in prefrontal and premotor cortical regions. The main predictors of interest will be motor and cognitive DT costs. Covariates will include age, sex, education, cognition, balance, mood, and disease severity in the PD group. Spatiotemporal gait parameters, including gait speed, step length, stride length, step time, base of support, double support, stance phase, and variability, will be recorded using the GAITRite system, and DT costs will be calculated for selected parameters. Cortical activation will be assessed using a 66 channel wearable fNIRS system with short separation channels. DISCUSSION: By combining randomized task blocks, separate motor and cognitive conditions, broader cortical coverage, and concurrent neural and gait assessment across three groups annually, this protocol is expected to provide a comprehensive characterization of cognitive motor interference during walking and its evolution, supporting interpretation of cortical and behavioral responses. The study may help distinguish age related adaptations from PD specific alterations and clarify whether increased cortical recruitment during DT gait reflects compensation, reduced neural efficiency, or ceiling effects, refining understanding of gait automaticity decline and informing rehabilitation and non invasive brain stimulation approaches.

Introduction: Physical activity during pregnancy can be tracked directly by accelerometer measurements and indirectly by validated questionnaires. Considering the advancement of the Internet of Things (IOT), managing and/or monitoring physical activities can be better explored to analyze individuals, as well as indirectly compare the intensity and domains of physical activities carried out by pregnant women. The project, called 'EVA'(Expert Virtual Assistant), suggests combining several fields of knowledge to obtain better information about physical activity during pregnancy, surpassing the claim made in previous research that studying and measuring the duration of daily physical activities in pregnant women is a challenge. Objective: In the present study, we present the results of the first stage of the EVA project, which aims to develop a Virtual Assistant (VA) in Portuguese, providing examples of health management features for monitoring Physical Activity measurements for pregnant women assisted in the Unified Health System (SUS) and the adaptation of the Pregnancy Physical Activity Questionnaire (PPAQ). Methods and Analysis: The methods used were developed in two stages: adapting the physical activity questionnaire and building the Virtual Assistent to monitor physical activities. Thirty pregnant women who used the Unified Health System (SUS) in the city of Ribeir&atildeo Preto, Brazil participated in the study. The pregnant women wore sensor wristbands (accelerometers) and answered the sociodemographic, lifestyle and physical activity questionnaires via an application developed for this study. Results: The questionnaire used was the PPAQ adapted for Brazilian pregnant women. The most important changes were in the occupational domain for the house cleaning and in sedentary behavior activities. In the pilot study, it was observed that pregnant women spend more energy at home and in light and moderate intensity activities. textbfConclusion:This study made important contributions to evaluating PA in pregnant women. The proposal and studies for the construction of the AV-EVA, the inclusion of a specific occupational domain for pregnant women with domestic occupations and the new cutoff points for PA intensity measurements obtained via accelerometers.

Background: Accurate evaluation of fine motor abilities is a key aspect of neurological rehabilitation. However, conventional approaches like goniometry are limited by variations among raters and their difficulty in detecting active movement. On the other hand, computer vision-based software delivers non-invasive and quantitative analysis of hand movements. An innovative computer-vision-based software tool, F.A.I.R. Chance(C), was developed to track and analyze individual finger joint movements on a camera-equipped laptop and give real-time numerical feedback. However, its metrics require validation in a healthy population before the tool can be used for clinical purposes. Objective: To assess the reliability and validity of finger movement assessment by the F.A.I.R. Chance computer vision-based tool in healthy adult participants. Methods: An observational cross-sectional study was done at MGM School of Physiotherapy, comprising 30 healthy participants between 18 and 60 years of age. Finger movements like flexion, extension, abduction, and adduction were measured with a standard handheld goniometer. These same finger movements were then measured with the tool at two time points separated by a 30-minute interval to determine the test-retest reliability. The tool's measurements were compared with the goniometric measurements to determine its concurrent validity. Test retest reliability was checked by the Intra-class Correlation Coefficient ICC (2,1), while concurrent validity was tested through Pearson's correlation coefficients. Results: Metacarpophalangeal and proximal interphalangeal joint motions demonstrated moderate to good test-retest reliability (ICC: 0.716-0.953) for the F.A.I.R. Chance tool. However, distal interphalangeal joint movements had lower consistency. Good reliability (ICC: 0.754-0.908) was seen for movements of abduction and adduction in the fingers. Strong concurrent validity for extension movements of the metacarpophalangeal joints (r=0.760-0.914) and moderate concurrent validity for flexion movements of the metacarpophalangeal joints (r=0.427-0.604) was demonstrated for all fingers for the F.A.I.R. Chance tool. Concurrent validity for adduction and abduction movements demonstrated a low to fair correlation with goniometric measurements (r=0.210-0.440). This is consistent with previous research showing poor agreement between goniometry and adduction-abduction movements of the fingers. Conclusion: The F.A.I.R. Chance tool shows good reliability and acceptable concurrent validity to assess fine motor movements in the healthy adult population. This sets a basis for further clinical study of the tool in the target population with fine motor impairments. Keywords: artificial intelligence; assistive technology; computer vision; fine motor evaluation; hand function;

Wearable digital health technologies may complement traditional gait assessments in amyotrophic lateral sclerosis (ALS) by sensitively capturing real-world mobility changes. In this study, we validated six digital gait metrics derived from ankle-worn sensors in a natural history cohort of 182 individuals with ALS. Investigated metrics correspond to various aspects of gait, including volume, speed, intensity, similarity, variability, and fragmentation. Longitudinal analyses showed significant declines in step count, peak cadence, stride intensity, and stride similarity, with increasing stride duration variability and walking fragmentation over 52 weeks. Many participants exhibited greater relative change in the gait metrics than the self-reported ALS Functional Rating Scale-Revised (ALSFRS-RSE). Stratified analyses revealed that digital metrics captured significant functional decline even in participants with stable walking scores on the ALSFRS-RSE. These findings support the potential utility of these metrics for disease monitoring in ALS clinical care and trials.

Engagement is widely recognised as central to learning and academic achievement. Electrodermal activity (EDA) has emerged as an objective physiological indicator of engagement, as it measures sympathetic nervous system activation. However, the high cost of wearable EDA sensors has limited its widespread application. This study answers the call for affordable, high-temporal-resolution engagement measures by validating a video-based quantitative assessment method. Researchers collected 75 minutes of synchronised EDA and video data from 12 upper secondary students (aged 17-18) during regular instruction. Novel software was developed to analyse student movement and sound level for academically relevant content. The OpenPose AI model for pose estimation was also applied. This approach produced six distinct movement variables: two AI-based and four non-AI-based. Six linear models using varying movement variables and sound level were tested to predict tonic EDA levels. All models effectively predicted EDA levels, with non-AI-based movement metrics outperforming AI-based alternatives. The four non-AI-based movement models showed similar performance, indicating that compressed versions reduced computational time without sacrificing predictive power. These findings validate a novel, objective method for comparing engagement across learning activities on short timescales. This method is particularly useful for collaborative learning environments and enables controlling for movement and sound in quantitative classroom analyses.

Background Continuous health monitoring enables early detection of diseases and improves therapeutic outcomes. Non-intrusive biosignal sensors, such as capacitive ECG (cECG), offer a practical solution for daily monitoring in private environments, such as smart homes and vehicles. However, artifacts reduce signal quality and compromise reliability. Methods Following a registered report protocol (Warnecke JM et al. Plos One. 2021; 16(7):e0254780), we record data of 44 subjects and develop an artifact index for cECG. We use three signal quality indices (SQIs): the correlation of QRS complexes (corSQI), the R-peak detection consistency (bSQI) and the absolute amplitude ratio (aSQI). Our index classifies overlapping 10s segments with a step-width of 2s into clean or artifact segments. We label a 2s interval as artifacts if all five overlapping segments indicate artifacts. We record cECGs using an armchair with integrated electrodes in a single-arm study involving 44 subjects performing two activities -- reading and watching television (TV); for 11 minutes each. We record a time-synchronized reference ECG with skin electrodes on the chest. To evaluate the artifact index, we compare it with manually generated ground truth. Moreover, we evaluate the clothing materials cotton, linen, jeans, and polyester in 5 subjects. Results Watching TV results in longer, continuously clean signal durations than reading. On average, 88.3% of the signal has a minimum continuous clean duration of 10s, versus 79.8% during reading. All clothing configurations achieve a clean signal duration exceeding 10s. Among the SQI metrics, bSQI performs best, achieving an accuracy of 90.7% and an F1 score of 79.9%. Combining the three SQI metrics in a voting approach improves accuracy to 92.0% and F1 score to 82.1%. Discussion Our artifact index automatically distinguishes clean from artifact cECG segments, promoting health monitoring in unsupervised real-world settings, earlier disease detection, and preventive health management. A limitation is the investigation of only two scenarios (reading and watching TV).

To explore the safety of combined use of lidocaine/prilocaine aerosol and condoms of different materials, this study conducted compatibility tests between them. By observing changes in various physical properties of condom materials after exposure to the aerosol, the compatibility of different polymer materials with the aerosol was analyzed.The results showed that within 15 minutes of exposure to the aerosol, there was no significant difference in all physical properties of natural rubber latex condoms compared with the blank control group (P>0.05), indicating they can be used together. In contrast, obvious changes in physical properties of polyurethane condoms occurred within 5 minutes of exposure (P<0.05), and their performances failed to meet industrial application standards, so combined use is strictly prohibited.This study clarifies the compatibility differences between two mainstream condom materials and lidocaine/prilocaine aerosol, providing experimental evidence and theoretical references for rational matching in clinical and daily use as well as avoiding potential safety risks.

AIMS Cardiometabolic risk factors may impair health by altering the autonomic modulation of the cardiovascular system, a physiological process described by heart rate (HR) circadian oscillations. However, the impact of cardiometabolic health determinants on HR circadian oscillations remains scarcely characterized in real-world, population-based settings. To address this, we applied digital health technologies to investigate how cardiometabolic health determinants shape HR circadian oscillations in a real-world cohort of individuals free of cardiometabolic diseases. METHODS First, a 10-fold cross-validation of a model was performed, aiming at mitigating wearables measurement error caused by motion artifacts. This process was informed by 10,056 epochs of concurrent wearable-derived and polysomnographic HR assessment, yielding an average 1.3 bpm reduction in wearables measurement error. We subsequently applied this model to over 2 million 1-minute epochs of HR data, derived from 7-day continuous actigraphic recordings of 245 individuals free of cardiometabolic disorders. Functional-on-scalar regression modelling and both parametric and nonparametric analyses characterized HR circadian profiles and their relationships with demographics, lifestyle, chronotype, sleep health, and chronic insomnia diagnosis. A 6-dimension sleep health index was calculated. RESULTS Sex, chronotype, and sleep health predominantly shaped HR circadian oscillations. In detail, females consistently showed higher HR across the 24 hours. Moreover, chronotype was associated to a phase shift in HR circadian profiles, with later timings corresponding to eveningness. Notably, sleep health impacted HR circadian oscillations in a dose-dependent fashion: each additional impaired sleep dimension was associated with a 1.2 bpm HR increase during nighttime, alongside reduced circadian robustness and delayed oscillation timings. Finally, the earlier occurrence of morning HR peaks served as a digital biomarker of insomnia (80% specificity, 74% sensitivity). CONCLUSIONS This work provides a digital health framework to characterize HR circadian oscillations in free-living populations and supports its clinical utility in capturing the autonomic disruptions related to cardiometabolic health determinants.

Background. Lung metastases in osteosarcoma (OS) are the main cause of the death. The accuracy of the diagnosis of nodules by computed tomography (CT) of the lungs is critically important for determining the disseminated stage of the disease and planning surgical treatment. The use of artificial intelligence (AI) in the search for lung nodules increases the accuracy of diagnosis and reduces the chance of missing metastases. Objective: to evaluate the accuracy of lung nodules diagnosis in adolescents with OS using AI. Methods. A retrospective assessment of CT scans of adolescents with OS was performed. A pathological nodule with an average size of [&ge;]4 mm was considered a target finding. The diagnostic accuracy of an AI algorithm previously trained on an adult dataset was evaluated, and the number of false positives (FP) and false negatives (FN) was determined. Sensitivity, specificity, accuracy, area under the ROC curve (AUC), positive predictive value, negative predictive value, and F1-measure were calculated. Based on the obtained results, the effectiveness of the algorithm was assessed. Results. 248 CT scans of adolescents with OS were evaluated. The following results were obtained: in 5 cases, the AI algorithm showed a FP result (2.02%), in 34 cases, it showed a FN result (13.71%), and in 209 cases, a correct result (both true positive and true negative) (84.27%). The diagnostic accuracy of the algorithm was 0.843 (95% CI 0.794-0.887). The application of the AI algorithm in the practice of an X-ray doctor in a specific clinical task would allow to increase the sensitivity from 0.805 to 0.891, while ensuring an absolute decrease in the number of FN results by 8.59% and a relative decrease by 44%. Conclusion. The obtained results confirm the practical value of the application of the AI algorithm and justify the implementation of AI-assisted systems in the diagnostic protocols for lung metastases in adolescents with OS.

3D scanners have revolutionised how podiatrists capture foot morphology in order to design custom orthoses (insoles). While various 3D scanning technologies are used in clinical practice, they vary greatly in cost and ease of use and many of these are not specifically designed for podiatry applications. There is limited literature comparing accuracy between scanners, and many approaches require prolonged scan times during which the patient must remain still. Multicamera photogrammetry offers a promising solution by enabling high-quality, rapid 3D scanning which other devices cannot provide. This study compared the accuracy and clinical utility of four 3D scanners. One was a high accuracy reference scanner (Artec Spider) which was used as a gold standard. Two further scanners which are commonly used in the clinic were also investigated (Apple iPad 6 with Structure Sensor attachment 'iPad', and Envisic VeriScan Podiatric Scanner 'laser') and these were directly compared with a novel prototype multicamera photogrammetry 3D scanner. The left feet of 20 healthy volunteers were scanned using each of the four devices and scans were evaluated for accuracy, completeness, and acquisition and processing times. All scanners produced clinically acceptable scans, with the novel photogrammetry scanner demonstrating superior accuracy. Scan times varied significantly between scanners, with the photogrammetry device capturing scans much faster. All scanners had acceptable levels of completeness, though the iPad and photogrammetry outperformed the laser scanner. These results provide a valuable tool for clinics seeking guidance on scanner selection and highlight the benefits of instantaneous photogrammetry scanning to improve workflow efficiency and accessibility.

Digital health technologies (DHT) offer a promising solution to the timely identification of early Alzheimer's disease (eAD) to enable early treatment. This study evaluated the feasibility, acceptability, adherence, reliability, and preliminary clinical and content validity of the novel AD Digital Assessment Suite (AD-DAS). 123 individuals (32 healthy controls (HC), 31 amyloid-PET negative (SCDn), 30 amyloid-PET positive (SCDp) with subjective cognitive decline, and 30 early AD (eAD)) participated. AD-DAS was remotely deployed for 28 days. Remote testing was feasible (97.6% completers), acceptable (>85% ''good''), and associated with high adherence (96%). Metrics showed moderate to excellent test-retest reliability (ICC 0.53-0.91), associations with clinical comparators (adjusted R2 0.01-0.24), differentiated eAD from other known groups (absolute log odds differences 0.6-3.28), and correlated with brain atrophy in expected regions. Episodic and working memory AD-DAS metrics differentiated SCDp from SCDn participants. These preliminary findings suggest that AD-DAS may be a promising tool for detecting cognitive impairments in early AD stages.

Background: Wearable technologies enable scalable and continuous monitoring of emotional states through passive sensing of physiological and behavioral signals. However, conventional learning approaches often struggle to model the complex temporal, contextual, and relational dependencies underlying human emotions. To address these limitations, we propose a graph-based framework that represents multimodal wearable observations as heterogeneous knowledge graphs enriched with semantic information derived from Large Language Models (LLMs), enabling richer contextual understanding beyond raw sensor measurements. Methods: We constructed a heterogeneous knowledge graph using multimodal Fitbit physiological signals and affective self-report data collected from 45 users. Framing mood prediction and emotion detection was formulated as both binary and ternary node classification tasks. We evaluated five baseline heterogeneous Graph Neural Network (GNN) architectures and compared them with the proposed Semantically Gated Augmented Graph Neural Network (SeGA-GNN) framework, which dynamically integrates LLM-generated semantic embeddings into graph representations through a gated cross-modal fusion mechanism. Results: The baseline GNN models achieved strong performance, with classification accuracies ranging from 0.7525 to 0.9739 for binary classification and 0.6249 to 0.9699 for ternary classification. The proposed SeGA framework consistently improved predictive performance across most architectures. In particular, semantic augmentation transformed the HAN model from moderate baseline performance into near-perfect emotion recognition capability, achieving SeGA-HAN Accuracy = 0.9988 and AUC = 1.0000 for binary classification and Accuracy = 0.9979 and AUC = 1.0000 for ternary classification. Discussion and Conclusion: Integrating LLM-derived semantic contextualization into heterogeneous graph learning enables effective modeling of contextual information that is not directly captured by wearable physiological signals alone. The proposed SeGA-GNN framework demonstrates that adaptive semantic fusion substantially improves the accuracy, robustness, and interpretability of wearable-based emotion detection. These findings establish a promising direction for next-generation wearable affective computing systems and intelligent emotion-aware applications.

Background: Improvements in health technology offer opportunities for remote disease screening, diagnosis and monitoring. The Withings Sleep Analyzer (WSA), an under mattress ballistocardiograph sensor able to detect body movement, breathing, and cardiac ejection is a promising technology for the non-invasive detection and monitoring of neurodegenerative diseases. InSleep46 aims to evaluate whether the WSA is able to detect preclinical Alzheimer's disease in members of the 1946 British Birth cohort, now in their late 70s. Objectives: To assess feasibility of deployment of a remote sleep, circadian and physiological monitoring device in a population of older adults. Participants: 356 participants from the Insight 46 neuroimaging sub-study (1946 British Birth Cohort), all born in one week in March 1946. Methods: We describe remote recruitment, device installation, and troubleshooting protocols. Feasibility analysis examined participant characteristics associated with recruitment and successful device set-up using logistic regression. Troubleshooting events for device installation and maintenance were recorded over a mean 14-month follow-up period. Results: During the feasibility analysis period, 263 (74%) participants, mean (SD) age 77 years (0.47) agreed to take part, of whom 245 (93%) successfully set up the WSA. Recruitment and successful set up of the WSA were not dependent on cognitive ability, socioeconomic position, or educational attainment. 162 (62%) of recruited individuals required [&ge;]1 troubleshooting call (mean 2.3 per participant, range 0-16). 603 calls were required in total. Conclusion: Deployment of a remote sleep and physiological monitoring device in an older adult population is feasible. Most participants required individualised assistance to set up the device. For the technology to be widely implemented, the set up must be accessible, with dedicated support available.

Wearable EEG devices enable home sleep monitoring but require systematic spectral validation before their physiological outputs can serve as proxies for polysomnographic features. This study provides comprehensive spectral validation of the Zmax EEG headband against concurrent PSG using the Wearanize+ dataset. Seventy-one participants with adequate signal quality underwent simultaneous home PSG and Zmax recording. Bandpower correspondence, calibration robustness, within-subject reliability, lateralisation, and spindle detection were evaluated across all sleep stages. Zmax systematically underestimates bandpower across all frequency bands (bias -0.41 to -0.74 log units), attributable to the active Fpz reference electrode. A per-subject N2-referenced calibration eliminates this bias; N2 calibration outperformed N3 and REM alternatives (mean post-calibration r=0.601 vs 0.479 and 0.489). Post-calibration spectral correspondence was strong for alpha (N3: r=0.806) and sigma (N3: r=0.752). Within-subject reliability was excellent (split-half r>0.99). Demographic factors explained less than 4% of offset variance. Lateralisation analysis was underpowered (36-39% power; N=194 required for 80% power). Spindle under-detection was traced to YASA's relative sigma power pre-filter; lowering this threshold recovered PSG-equivalent counts with near-zero bias. These findings establish a validated calibration framework and evidence-based feature selection recommendations for Zmax-based sleep biomarker research.

Background Slow walking in older adults with mild parkinsonian signs (MPS) is a complex, multifactorial phenomenon arising from the cumulative burden of subclinical age-associated pathologies. This decline reflects age-associated neuronal loss in the dopaminergic system. A recent study suggests that levodopa treatment may enhance gait parameters. The goal of this small pilot study is to explore the effect of levodopa treatment on slow walking gait in older adults with MPS. Method This study was a randomized, placebo-controlled clinical pilot trial. Slow walking older adults without clinical evidence of PD were recruited and randomized into 2 groups (active treatment group or placebo control group). Participants in the active group were pre-treated with carbidopa for three days, followed by carbidopa-levodopa for seven days. Spatiotemporal gait parameters were evaluated at baseline and post-intervention. Results Gait factor analysis identified three main factors explaining gait characteristics at baseline, which included gait efficiency, gait rhythmicity, and gait turning.No effect of treatment was observed in the placebo group (p=0.111, p=0.616), no group difference was observed between the placebo and active group at baseline ({beta}=0.310, p=0.547), but a strong trend for a treatment-related increase was observed in the active treatment group ({beta}=0.506, p=0.076). Conclusion Our preliminary data suggest that sustained levodopa treatment (one week) in conjunction with carbidopa pre-treatment and concomitant carbidopa supplementation is feasible in slow walking older adults with MPS. Moreover, the data indicate potential efficacy, showing improvements in cadence, and step durations.

Background Gait impairment is a central sign of cervical spondylotic myelopathy (CSM) that is typically evaluated through subjective patient-reported questionnaires or objective in-clinic measures. These systems require substantial resources to administer and are poorly suited for longitudinal monitoring, however, emerging smartphone applications present an efficient alternative. We developed and assessed the validity of a data processing framework based on the SynapTrack smartphone application to assess gait function in individuals with CSM. Methods Participants completed walking tasks which were recorded on both the SynapTrack app and a gold standard gait mat. Acceleration data extracted from the smartphone by the app were filtered and processed to produce gait cycle features including velocity, step time, waveform features and frequency domain features. Standard gait features were compared across the two methods by correlation and Bland-Altman plots to assess validity. App-based gait features were then compared to the standard modified Japanese Orthopedic Assessment (mJOA) assessment to determine construct validity through correlation and ability to discriminate between individuals with CSM and healthy controls. Finally, intraclass correlation coefficients and coefficients of variation were used to measure test-retest reliability and standard variation across app features. Results A total of 110 participants were included in this study, of which 55 (50%) had CSM, 24 (22%) had peripheral neuropathy, and 31 (28%) were healthy controls. SynapTrack gait measures including velocity, step time, and double support showed strong validity as indicated through Bland-Altman plots and high correlation (>0.8) with mat features. In addition to the gait features, acceleration root mean square, acceleration crest, spectral entropy, and dominant frequency showed strong construct validity compared to the mJOA across correlation (0.2-0.54), trend test (p < 0.001), and AUROC (0.62-0.79) analyses. ICCs showed moderate test-retest reliability (0.52-0.67). Discussion The proposed framework for processing gait data showed strong validity compared to the gold standard mat and high construct validity compared to the mJOA suggesting the utility of the SynapTrack app as an efficient alternative to existing methods. The confirmation of gait metrics related to CSM severity and identification of relevant waveform and frequency domain features present opportunities to use smartphone apps to develop ecologically valid data driven markers of CSM severity.